Clinicopathological features and outcomes of choriocarcinoma: A retrospective analysis from an Indian tertiary cancer center

Background: Choriocarcinoma is the most common form of gestational trophoblastic neoplasia seen by medical oncologists. It is a rare condition and data related to its long-term outcomes from the Indian subcontinent are sparse. Objectives: The primary objective of this study was to assess the clinico...

Full description

Bibliographic Details
Main Authors: Joydeep Ghosh, Sayantika Dey, Debapriya Mandal, Sandip Ganguly, Bivas Biswas, Deepak Dabkara, Anik Ghosh, Basumita Chakraborty, Arunava Roy, Shweta Rai, Sonia Mathai, Jaydip Bhaumik
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2021-01-01
Series:Cancer Research, Statistics, and Treatment
Subjects:
Online Access:http://www.crstonline.com/article.asp?issn=2590-3233;year=2021;volume=4;issue=3;spage=486;epage=491;aulast=Ghosh
_version_ 1818820987917959168
author Joydeep Ghosh
Sayantika Dey
Debapriya Mandal
Sandip Ganguly
Bivas Biswas
Deepak Dabkara
Anik Ghosh
Basumita Chakraborty
Arunava Roy
Shweta Rai
Sonia Mathai
Jaydip Bhaumik
author_facet Joydeep Ghosh
Sayantika Dey
Debapriya Mandal
Sandip Ganguly
Bivas Biswas
Deepak Dabkara
Anik Ghosh
Basumita Chakraborty
Arunava Roy
Shweta Rai
Sonia Mathai
Jaydip Bhaumik
author_sort Joydeep Ghosh
collection DOAJ
description Background: Choriocarcinoma is the most common form of gestational trophoblastic neoplasia seen by medical oncologists. It is a rare condition and data related to its long-term outcomes from the Indian subcontinent are sparse. Objectives: The primary objective of this study was to assess the clinicopathological characteristics and clinical outcomes of patients with of choriocarcinoma; the secondary objective was to assess the correlation of outcomes with risk stratification. Materials and Methods: This single-center retrospective study was conducted at the Tata Medical Center, a tertiary cancer center in West Bengal, India. We identified all the cases of choriocarcinoma treated at our hospital from the electronic medical records and noted their baseline characteristics, treatment details, and clinical outcomes. Descriptive statistics were used for baseline characteristics, and the Kaplan–Meier method was used for the survival analysis. Results: A total of 24 patients were included in the study. The median age of the patients was 29 years (interquartile range, 25.9–39.5). The median time interval from the last pregnancy was 5 months (range, 0 months to 11 years). The World Health Organization risk score was low in 8 (33.3%) and high in 16 (66.7%) patients. There were 6 (25%) patients who received single-agent chemotherapy, 14 (66.7%) received the EMA-CO (etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine) regimen, and 1 (4.7%) received the VIP (etoposide, ifosfamide, and cisplatin) regimen, with the latter 2 being given only to high-risk patients. The median follow-up was 10.9 months (95% confidence interval [CI], 4.2–28.5). The median progression-free survival was not reached (NR) (95% CI, 7.2–NR). Similarly, the median overall survival was NR (95% CI, 10.56–NR). Conclusion: Our study provides real-world data for this rare malignancy and reinforces the fact that choriocarcinoma is a highly curable disease. Despite the clinicopathological variations in the different parts of the country, the long-term outcomes are favorable.
first_indexed 2024-12-18T23:01:02Z
format Article
id doaj.art-b741e091ac794f67bb72fd77020ecd53
institution Directory Open Access Journal
issn 2590-3233
2590-3225
language English
last_indexed 2024-12-18T23:01:02Z
publishDate 2021-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Cancer Research, Statistics, and Treatment
spelling doaj.art-b741e091ac794f67bb72fd77020ecd532022-12-21T20:48:36ZengWolters Kluwer Medknow PublicationsCancer Research, Statistics, and Treatment2590-32332590-32252021-01-014348649110.4103/crst.crst_124_21Clinicopathological features and outcomes of choriocarcinoma: A retrospective analysis from an Indian tertiary cancer centerJoydeep GhoshSayantika DeyDebapriya MandalSandip GangulyBivas BiswasDeepak DabkaraAnik GhoshBasumita ChakrabortyArunava RoyShweta RaiSonia MathaiJaydip BhaumikBackground: Choriocarcinoma is the most common form of gestational trophoblastic neoplasia seen by medical oncologists. It is a rare condition and data related to its long-term outcomes from the Indian subcontinent are sparse. Objectives: The primary objective of this study was to assess the clinicopathological characteristics and clinical outcomes of patients with of choriocarcinoma; the secondary objective was to assess the correlation of outcomes with risk stratification. Materials and Methods: This single-center retrospective study was conducted at the Tata Medical Center, a tertiary cancer center in West Bengal, India. We identified all the cases of choriocarcinoma treated at our hospital from the electronic medical records and noted their baseline characteristics, treatment details, and clinical outcomes. Descriptive statistics were used for baseline characteristics, and the Kaplan–Meier method was used for the survival analysis. Results: A total of 24 patients were included in the study. The median age of the patients was 29 years (interquartile range, 25.9–39.5). The median time interval from the last pregnancy was 5 months (range, 0 months to 11 years). The World Health Organization risk score was low in 8 (33.3%) and high in 16 (66.7%) patients. There were 6 (25%) patients who received single-agent chemotherapy, 14 (66.7%) received the EMA-CO (etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine) regimen, and 1 (4.7%) received the VIP (etoposide, ifosfamide, and cisplatin) regimen, with the latter 2 being given only to high-risk patients. The median follow-up was 10.9 months (95% confidence interval [CI], 4.2–28.5). The median progression-free survival was not reached (NR) (95% CI, 7.2–NR). Similarly, the median overall survival was NR (95% CI, 10.56–NR). Conclusion: Our study provides real-world data for this rare malignancy and reinforces the fact that choriocarcinoma is a highly curable disease. Despite the clinicopathological variations in the different parts of the country, the long-term outcomes are favorable.http://www.crstonline.com/article.asp?issn=2590-3233;year=2021;volume=4;issue=3;spage=486;epage=491;aulast=Ghoshchoriocarcinomaindiaoutcomereal world
spellingShingle Joydeep Ghosh
Sayantika Dey
Debapriya Mandal
Sandip Ganguly
Bivas Biswas
Deepak Dabkara
Anik Ghosh
Basumita Chakraborty
Arunava Roy
Shweta Rai
Sonia Mathai
Jaydip Bhaumik
Clinicopathological features and outcomes of choriocarcinoma: A retrospective analysis from an Indian tertiary cancer center
Cancer Research, Statistics, and Treatment
choriocarcinoma
india
outcome
real world
title Clinicopathological features and outcomes of choriocarcinoma: A retrospective analysis from an Indian tertiary cancer center
title_full Clinicopathological features and outcomes of choriocarcinoma: A retrospective analysis from an Indian tertiary cancer center
title_fullStr Clinicopathological features and outcomes of choriocarcinoma: A retrospective analysis from an Indian tertiary cancer center
title_full_unstemmed Clinicopathological features and outcomes of choriocarcinoma: A retrospective analysis from an Indian tertiary cancer center
title_short Clinicopathological features and outcomes of choriocarcinoma: A retrospective analysis from an Indian tertiary cancer center
title_sort clinicopathological features and outcomes of choriocarcinoma a retrospective analysis from an indian tertiary cancer center
topic choriocarcinoma
india
outcome
real world
url http://www.crstonline.com/article.asp?issn=2590-3233;year=2021;volume=4;issue=3;spage=486;epage=491;aulast=Ghosh
work_keys_str_mv AT joydeepghosh clinicopathologicalfeaturesandoutcomesofchoriocarcinomaaretrospectiveanalysisfromanindiantertiarycancercenter
AT sayantikadey clinicopathologicalfeaturesandoutcomesofchoriocarcinomaaretrospectiveanalysisfromanindiantertiarycancercenter
AT debapriyamandal clinicopathologicalfeaturesandoutcomesofchoriocarcinomaaretrospectiveanalysisfromanindiantertiarycancercenter
AT sandipganguly clinicopathologicalfeaturesandoutcomesofchoriocarcinomaaretrospectiveanalysisfromanindiantertiarycancercenter
AT bivasbiswas clinicopathologicalfeaturesandoutcomesofchoriocarcinomaaretrospectiveanalysisfromanindiantertiarycancercenter
AT deepakdabkara clinicopathologicalfeaturesandoutcomesofchoriocarcinomaaretrospectiveanalysisfromanindiantertiarycancercenter
AT anikghosh clinicopathologicalfeaturesandoutcomesofchoriocarcinomaaretrospectiveanalysisfromanindiantertiarycancercenter
AT basumitachakraborty clinicopathologicalfeaturesandoutcomesofchoriocarcinomaaretrospectiveanalysisfromanindiantertiarycancercenter
AT arunavaroy clinicopathologicalfeaturesandoutcomesofchoriocarcinomaaretrospectiveanalysisfromanindiantertiarycancercenter
AT shwetarai clinicopathologicalfeaturesandoutcomesofchoriocarcinomaaretrospectiveanalysisfromanindiantertiarycancercenter
AT soniamathai clinicopathologicalfeaturesandoutcomesofchoriocarcinomaaretrospectiveanalysisfromanindiantertiarycancercenter
AT jaydipbhaumik clinicopathologicalfeaturesandoutcomesofchoriocarcinomaaretrospectiveanalysisfromanindiantertiarycancercenter